Year archive

PharmaSGP Holding SE — 2024 filings

All 21 regulatory filings released by PharmaSGP Holding SE (PSG) in 2024, sourced directly from the official regulator.

21 Filings

2024 Period

2024 filings (21)

Filing	Released	Lang
Q3 statement / Q3 financial report 2024 Interim / Quarterly Report 9M 2024	2024-11-29	English
Q3 statement / Q3 financial report 2024 Interim / Quarterly Report 9M 2024	2024-11-28	English
Q3 statement / Q3 financial report 2024 Interim / Quarterly Report 9M 2024	2024-11-28	English
PharmaSGP Holding SE: FUTRUE GmbH, buy Director's Dealing	2024-11-25	English
CEO change at PharmaSGP Holding SE: Peter Gerckens succeeds Natalie Weigand as of January 1, 2025 Board/Management Information	2024-11-05	English
PharmaSGP Holding SE: Peter Gerckens succeeds Natalie Weigand as Chief Executive Officer Board/Management Information	2024-11-05	English
Declaration of Voting Results & Voting Rights Announcements 2024 Declaration of Voting Results & Voting Rights Announcements	2024-10-07	English
PharmaSGP Holding SE has purchased 477,701 own shares through its public share repurchase offer Transaction in Own Shares	2024-10-01	English
Half-yearly financial report 2024 Interim / Quarterly Report H1 2024	2024-09-26	English
Report Publication Announcement 2024 Report Publication Announcement	2024-09-19	English
PharmaSGP continues dynamic growth path in the first half of 2024 Earnings Release H1 2024	2024-09-12	English
PharmaSGP Holding SE resolves on public share repurchase offer to buy back own shares for up to 594,405 shares Transaction in Own Shares	2024-09-12	English
PharmaSGP Holding SE: Annual General Meeting approves full distribution of the Groups profit for 2023 following a successful business performance AGM Information	2024-06-27	English
PharmaSGP Holding SE strengthens the Management Board to further accelerate growth Board/Management Information	2024-06-21	English
Q1 statement / Q1 financial report 2024 Interim / Quarterly Report Q1 2024	2024-05-28	English
PharmaSGP continues dynamic business development with significant revenues growth in Q1 2024 Earnings Release Q1 2024	2024-05-14	English
Annual financial report 2023 Annual Report FY 2023	2024-04-29	English
Report Publication Announcement 2024 Report Publication Announcement	2024-04-22	English
PharmaSGP Holding SE proposes an increased dividend of EUR 1.36 per share for 2023 Notice of Dividend Amount	2024-04-18	English
PharmaSGP exceeds the 100 million revenues mark in 2023 and plans further profitable growth in 2024 Earnings Release FY 2023	2024-04-16	English
Declaration of Voting Results & Voting Rights Announcements 2024 Declaration of Voting Results & Voting Rights Announcements	2024-01-04	English